Vinorelbine (Navelbine) : Burroughs Wellcome : Chemotherapeutic agent
	Vinorelbine (Navelbine) Clinical Research
	Vinorelbine (Navelbine) Side Effects
	Vinorelbine (Navelbine) & Cisplatin
	Paclitaxel (Taxol) & Vinorelbine (Navelbine)
	Gemcitabine (Gemzar) & Vinorelbine (Navelbine)

Clinical Research

Non-Small Cell Lung Cancer: A Study of Long-Term Survival After Vinorelbine (The Oncologist)
Julien, S., et al.
v.5, no.2 The Oncologist (April 2000): 115-119
Reports the results of a study that showed a percentage of patients with inoperable NSCLC can experience prolonged survival after treatment with single agent Navelbine.

Vinorelbine (Navelbine) - Recent MEDLINE Abstracts (PubMed)

Vinorelbine - Clinical Trials (ClinicalTrials.gov)

Side Effects

Navelbine (vinorelbine) (CancerBACUP)
Factsheet describes Navelbine (also called Vinorelbine), how it is given and some of its possible side effects. [11/02]

Vinorelbine (Navelbine) & Cisplatin

Vinorelbine/Cisplatin Improves Survival In Advanced NSCLC (cancernetwork.com)
v.7, no.11 Oncology News (November 1998)
Summarizes results of a phase III randomized study conducted by the Southwest Oncology Group (SWOG) demonstrating improved survival in patients with advanced NSCLC treated with vinorelbine (Navelbine) and cisplatin (Platinol) over those treated with cisplatin alone. Registration required for free access to cancernetwork.com. [11/98]

Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Non-Small Cell Lung Cancer (Journal of Clinical Oncology)
Abstract of a Journal of Clinical Oncology article (March 2000 issue) reporting the results of a study that found docetaxel and vinorelbine, both given every 2 weeks, is a highly active combination for the treatment of advanced NSCLC. [3/00]

Vinorelbine and Cisplatin - Recent MEDLINE Abstracts (PubMed)